The authors summarize the role of CXCR4 in progression and treatment of acute leukemia, and discuss the potential value of using CXCR4 antagonists as immunosensitizer for graft-vs-leukemia effects of allogeneic HSC transplantation.
[Cell Proliferation]
Sorry, but the selected Zotpress account can't be found.
